Encephalitis News and Research

Latest Encephalitis News and Research

West Nile Virus can become more widespread in Europe than previously thought, says new report

Potentially fatal mosquito-borne West Nile fever (WNF) can become much more widespread in Europe than previously thought, say scientists in a new report just out in the journal BMC Evolutionary Biology(1).

8 Dec 2009

Publication serves as a guide to build productive partnerships and overcome global health challenges

Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.

21 Nov 2009

Experts gather to outline the latest creative applications of DNA barcoding

The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others.

7 Nov 2009

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.

6 Nov 2009

Inner sense of cardiovascular state relies on two independent pathways, shows study

A new study suggests that the inner sense of our cardiovascular state, our "interoceptive awareness" of the heart pounding, relies on two independent pathways, contrary to what had been asserted by prominent researchers.

4 Nov 2009

Aethlon Medical begins collaborative biomarker program to study neurodegenerative disease

Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that it has initiated a collaborative biomarker discovery program with the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine and the Sports Legacy Institute (SLI).

3 Nov 2009

Scientists report a major step forward in the development of an effective therapy against Nipah virus

A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus.

31 Oct 2009

Avisio signs agreement to commercialize Instant Detect diagnostic technology

Avisio, Inc. announces the signing of a definitive agreement to commercialize Instant Detect, a portable nano-based diagnostic technology. Avisio, a publicly-traded commercialization company with a mission to unlock the value of high-potential assets and transform them into high-value businesses, now has the worldwide license to commercialize Instant Detect's ground-breaking portable diagnostic sensory technology.

28 Oct 2009

News outlets examine challenges with expanding global child immunization campaigns

Wednesday's release of the WHO, UNICEF and the World Bank joint report on childhood vaccines highlighted gains in recent global vaccination campaigns and also found that nearly 24 million infants worldwide don't get the recommended first-year vaccination.

23 Oct 2009

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

The National Institutes of Health has awarded a $15.7 million contract to UT Southwestern Medical Center and Northrop Grumman Corp. to develop an open-access national online database and analysis resource center that will help scientists study and combat viruses such as those that cause hepatitis, encephalitis, smallpox, acute respiratory distress and dengue fever, as well as newly emerging pathogenic viruses.

15 Oct 2009

Research finds 50 million people vaccinated against zoonotic brain infection

Research at the University of Liverpool has supported the vaccination of more than 50 million people against a zoonotic brain infection that affects thousands of children across Asia every year.

7 Oct 2009

Inviragen, SingVax merge their complementary vaccine pipelines

Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for infectious diseases prevalent in emerging economies.

6 Oct 2009

MSF calls on drug companies to pool HIV patents

Medecins Sans Frontieres (MSF) recently launched an e-mail campaign calling on nine of the world's largest pharmaceutical companies to "release their patents on specific HIV drugs into a collective pool that will increase access and affordability to treatment in developing countries," Inter Press Service reports (Borde, 10/1).

5 Oct 2009

Phase 1 clinical trial to test safety and activity of human MAB launched in India

MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.

1 Oct 2009

Virginia Tech student granted fellowship for research study on LaCrosse Virus disease

Camille Harris of Ridgeland, Mississippi, a graduate student in biological sciences at Virginia Tech, has been awarded a National Institutes of Health (NIH) Graduate Research Fellowship for her study of forest disturbance and its ecological impacts on LaCrosse Virus, a mosquito-borne disease that can cause seizures, coma, paralysis, and permanent brain damage in severe cases.

26 Sep 2009

New treatment strategies for multiple sclerosis

The drawback in the new immunotherapies in multiple sclerosis (MS) includMe severe infections that can be fatal. For example, treatment with natalizumab, which reduces the immune surveillance of the brain, can lead to the development of progressive multifocal leukoencephalopathy (PML), a typically fatal form of viral encephalitis.

10 Sep 2009

Avisio to acquire a portable sensory technology asset to instantly detect disease-causing pathogens

Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.

26 Aug 2009

Encephalitis News and Research

Latest Encephalitis News and Research

West Nile Virus can become more widespread in Europe than previously thought, says new report

Publication serves as a guide to build productive partnerships and overcome global health challenges

Experts gather to outline the latest creative applications of DNA barcoding

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

Inner sense of cardiovascular state relies on two independent pathways, shows study

Aethlon Medical begins collaborative biomarker program to study neurodegenerative disease

Scientists report a major step forward in the development of an effective therapy against Nipah virus

Avisio signs agreement to commercialize Instant Detect diagnostic technology

News outlets examine challenges with expanding global child immunization campaigns

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

Research finds 50 million people vaccinated against zoonotic brain infection

Inviragen, SingVax merge their complementary vaccine pipelines

MSF calls on drug companies to pool HIV patents

Phase 1 clinical trial to test safety and activity of human MAB launched in India

Virginia Tech student granted fellowship for research study on LaCrosse Virus disease

New treatment strategies for multiple sclerosis

Avisio to acquire a portable sensory technology asset to instantly detect disease-causing pathogens

USDA donates funds for teaching food safety awareness to AIDS patients

West Nile Virus threat continues in Pennsylvania

Pennsylvania's first case of West Nile in 2009 confirmed

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Encephalitis News and Research

Latest Encephalitis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in